Treatment of smoke inhalation by hyperbaric oxygen. (1985 study) Skip to main content
Clinical Study The Journal of emergency medicine 1985

Treatment of smoke inhalation by hyperbaric oxygen.

Hart GB, Strauss MB, Lennon PA, Whitcraft DD, The Journal of emergency medicine, 1985

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Doctors treated five people who were unconscious after breathing in smoke from house fires, using both a cyanide antidote kit and hyperbaric oxygen therapy.

What They Found

This is a case series of five smoke inhalation patients in which four of the five woke up within 15 minutes of reaching maximum treatment pressure and stayed neurologically intact, while the fifth patient died one week later. Carbon monoxide levels in the blood were high in all five patients, averaging 32 percent. Blood cyanide levels drawn before treatment averaged 1.62 micrograms per milliliter, with the highest level, 3.9 micrograms per milliliter, found in the patient who died, and the lowest, 0.35 micrograms per milliliter, in another patient. Because every patient received the cyanide antidote and hyperbaric oxygen together, the report cannot separate what each treatment contributed on its own.

What This Means for Canadian Patients

For Canadian patients with severe smoke inhalation and suspected cyanide poisoning, this small case series describes hyperbaric oxygen used alongside the standard cyanide antidote, with the authors calling hyperbaric oxygen a useful adjunct rather than a stand-alone treatment. With only five patients and one death, the report does not show that hyperbaric oxygen by itself changes outcomes, and it should not be read as a guarantee of recovery in similar cases.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is an uncontrolled case series of just five patients with no comparison group and no way to separate the effects of hyperbaric oxygen from those of the cyanide antidote, so the results cannot be generalized to other smoke inhalation cases.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 4093574
Year Published 1985
Journal The Journal of emergency medicine
MeSH Terms Adult; Aged; Ampicillin; Burns, Inhalation; Cephalosporins; Child, Preschool; Cyanides; Electrocardiography; Female; Humans; Hyperbaric Oxygenation; Infant; Male; Monitoring, Physiologic; Pneumonia

Cite This Study

Share

This study relates to Carbon Monoxide Poisoning. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology